Insilico at AACR: Four innovative posters demonstrating the power of generative AI
Meeting Announcement
Updates every hour. Last Updated: 22-Jun-2026 19:15 ET (22-Jun-2026 23:15 GMT/UTC)
At AACR 2026, Insilico will unveil four novel cancer inhibitors discovered via its end-to-end Pharma.AI platform. By harnessing trillions of data points and millions of molecular fragments, the platform integrates generative biology for target discovery with generative chemistry for de novo molecular design, accelerating the path from data to drug candidates.
NCCN brought together more than a thousand oncology professionals at the NCCN 2026 Annual Conference in Orlando, Florida, with hundreds more joining virtually. This year’s event featured educational sessions on the latest breakthroughs in cancer prevention and treatment, clinical guidelines updates, guidance for improving cancer center operations, plus panel discussions on critical issues in care delivery.
A new scientific study, published in Nature Health, reveals a strong link between exposure to agricultural pesticides in the environment and the risk of developing cancer. By combining environmental data, a nationwide cancer registry, and biological analyses, researchers from the IRD, the Institut Pasteur, the University of Toulouse, and the National Institute of Neoplastic Diseases (INEN) in Peru have shed new light on the role of pesticide exposure in the development of certain cancers.
Emerging evidence supports a relationship between chronic kidney disease and oral diseases, according to a recent review from University of Cincinnati College of Medicine researchers published in BMC Nephrology.
Multiple myeloma is a cancer in which plasma cells, which normally produce antibodies, multiply uncontrollably in the bone marrow. There is currently no cure. However, various therapies can stabilise the disease and alleviate symptoms. One such therapy is to treat the patient with their own stem cells. This often involves weeks in hospital. Using machine learning methods, a research team has now assessed the conditions in which some of the therapy can be safely carried out as an outpatient. The study was conducted by researchers from the Göttingen Campus Institute for Dynamics of Biological Networks (CIDBN) at the University of Göttingen, the University Medical Center Göttingen (UMG), and the University Medical Center Bielefeld (OWL). It was published in the journal npj digital medicine.
UC San Diego researchers reveal new insights into how breast cancer spreads, shedding new light on a common cause of cancer-related deaths.